A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
Clinical trial NCT03535415 · UNKNOWN
Trial details
- NCT number
- NCT03535415
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-25
- Primary completion
- 2020-09-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.